Mirati Therapeutics Inc. buy Global_Player
Start price
07.12.22
/
50%
€56.50
Target price
07.12.23
-
Performance (%)
-30.27%
End price
10.12.22
€39.40
Summary
This prediction ended on 10.12.22 with a price of €39.40. The BUY prediction by Global_Player for Mirati Therapeutics Inc. performed very badly with a performance of -30.27%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
According to Global_Player what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy Mirati Therapeutics Inc.
In the thread Trading Mirati Therapeutics Inc.
Stopped prediction by Global_Player for Mirati Therapeutics Inc.
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.10
05.10.23
05.10.23
-
05.10.24
05.10.24
-8.93%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
